Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|June 30, 2016
Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22Lamia Özgör, Carolin Brandl, Anthony Shock, et al.
European Journal of Immunology|February 17, 2021
Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritisCarolin Brandl, Laura Bucci, Georg Schett, et al.
Frontiers in Immunology|December 19, 2018
B Cell Siglecs-News on Signaling and Its Interplay With Ligand BindingSarah J Meyer, Alexandra T Linder, Carolin Brandl, et al.
Frontiers in Immunology|March 27, 2023
Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosusMarina A Korn, Marie Steffensen, Carolin Brandl, et al.
Journal of Applied Clinical Medical Physics|August 5, 2024
Improving the safety of radiotherapy treatment processes via incident-driven FMEA feedback loopsDominik Kornek, Michael Lotter, Juliane Szkitsak, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signalingJennifer Müller, Ingrid Obermeier, Miriam Wöhner, et al.
European Journal of Immunology|September 20, 2011
Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responsesKatrien Pletinckx, Benoit Stijlemans, Vladimir Pavlovic, et al.
International Journal of Molecular Sciences|October 13, 2021
Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor MicroenvironmentsFranziska Gsottberger, Carolin Brandl, Kerstin Wendland, et al.
Pageof 2